A look at the shareholders of Optiscan Imaging Limited (ASX:OIL) can tell us which group is most powerful. Institutions often own shares in more established companies, while it's not unusual to see ...

Assessing Optiscan Imaging Limited’s (ASX:OIL) past track record of performance is a useful exercise for investors. It allows us to understand whether the company has met or exceed expectations, which ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Optiscan’s confocal laser endomicroscopy promises to revolutionise cancer surgery so that it’s done right first time, every time But one important discipline remains stuck in the 19th century: the ...

The direct benefit for Optiscan Imaging Limited (ASX:OIL), which sports a zero-debt capital structure, to include debt in its capital structure is the reduced cost of capital. However, the trade-off ...

We don't think Optiscan Imaging's revenue of AU$1,322,144 is enough to establish significant demand. So it seems that the investors focused more on what could be, than paying attention to the current ...

June 24, 2008 In order to view cells at a high enough magnification to identify cancerous and pre-cancerous growths, doctors currently have to perform biopsy surgery - the invasive removal of cells so ...

Optiscan has revealed a novel microscopic imaging device designed specifically for the veterinary medicine market segment. Special Report: Optiscan has revealed a novel microscopic imaging device ...

Since earning FDA clearance for its automated glucose monitoring system in 2017, OptiScan has introduced the device to select hospitals in the U.S. and Europe. Now, the company has raised $20 million ...

Don't miss out on the headlines from Stockhead. Followed categories will be added to My News. Optiscan enters exclusive five-year collaboration deal with US-based drug company Long Grove ...